-
Our medical and healthcare experts helped create Estonia’s long-term personalised medicine programme
The aim of the extensive project initiated by the Ministry of Social Affairs in spring 2023 and carried out by the University of Tartu was to draw up a “Long-term personalised medicine programme for 2024-2034”. As a legal expert, the University of Tartu engaged the regional head of our medical and health care team, counsel […]
-
Novel public-private partnership contributes to the implementation of cancer control plan
We advised AstraZeneca, a global research-based biopharmaceutical company in relation to the company’s participation in a novel public-private partnership to improve lung cancer patient pathway in cooperation and thus contribute jointly to the implementation of the national cancer control plan. New approach National cancer control plan until year 2030 highlights the problem that cancer patients’ […]
-
YIT enters the largest ever residential to-let development project in the Baltic countries
We advised YIT, the largest Finnish urban developer and construction company and also significant in Northern Europe in general, on the establishment of a partnership involving the largest ever residential to-let development project in the Baltic countries, and on local law aspects in all three of the Baltic states regarding the joint venture’s structure. As […]
-
Synbase revolutionises evidence-based medicine databases
We assisted Synbase, an Estonian service provider for healthcare professionals, on tackling various data protection matters and launching its revolutionary web portal offering access to various evidence-based medicine databases. Supporting healthcare professionals Synbase saves healthcare professionals time by combining the latest knowledge in evidence-based medicine into a convenient, comprehensive service offered now both via an […]
-
Estonian health technology startup Antegenes seeks to expand
We prepared a legal analysis for Antegenes, a provider of novel genetic tests designed to assess personal cancer risks. The analysis explored the possibilities of Antegenes to expand to other countries. Expansion in mind For example, the health startup was facing the question if and on what conditions other European Union member states can limit […]